Impact of prior acute GVHD on chronic GVHD outcomes: A chronic graft versus host disease consortium study

Leukemia

Volumn 27, Issue 5, 2013, Pages 1196-1201

  Arora, M ^a   Pidala, J ^b   Cutler, C S ^c   Chai, X ^d   Kurland, B ^d   Jacobsohn, D A ^e   Pavletic, S Z ^f   Palmer, J ^g   Vogelsang, G ^h   Jagasia, M ⁱ   Schultz, K ^j   Lee, S J ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ VANDERBILT UNIVERSITY   (United States)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; CHRONIC GRAFT VERSUS HOST DISEASE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX;

EID: 84877609720     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.292     Document Type: Letter

References (15)

1. Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009; 114: 702-708.
2. Stewart BL, Storer B, Storek J, Deeg HJ, Storb R, Hansen JA et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 2004; 104: 3501-3506.
3. Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS et al. Chronic GVHD risk score: a center for international blood and marrow transplant research analysis. Blood 2011; 117: 6714-6720.
4. Wingard JR, Piantadosi S, Vogelsang GB, Farmer ER, Jabs DA, Levin LS et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 1989; 74: 1428-1435.
5. Akpek G, Zahurak ML, Piantadosi S, Margolis J, Doherty J, Davidson R et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001; 97: 1219-1226.
6. Arora M, Burns LJ, Davies SM, Macmillan ML, Defor TE, Miller WJ et al. Chronic graft-versus-host disease: a prospective cohort study. Biol Blood Marrow Transplant 2003; 9: 38-45.
7. Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406-414.
8. Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 1988; 72: 546-554.
9. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
10. Chronic GVHD Consortium. Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD. Biol Blood Marrow Transplant 2011; 17: 1114-1120.
11. Arai S, Jagasia M, Storer B, Chai X, Pidala J, Cutler C et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH consensus criteria. Blood 2011; 118: 4242-4249.
12. Pidala J, Vogelsang G, Martin P, Chai X, Storer B, Pavletic S et al. Overlap subtype of chronic graft vs host disease is associated with adverse prognosis, functional impairment, and inferior patient reported outcomes: a chronic graft vs host disease consortium study. Haematologica 2011; 97: 451-458.
13. Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: iv. response criteria working group report. Biol Blood Marrow Transplant 2006; 12: 252-266.
14. Kaplan EL, M P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
15. Cox D. Regression models and life tables. J R Stat Soc B 1972 1972; 34: 187-220.